The susceptibility of red blood cells to autoxidation in type 2 diabetic patients with angiopathy

被引:21
作者
Konukoglu, D
Akçay, T
Dinçer, Y
Hatemi, H
机构
[1] Istanbul Univ, Cerrahpasa Med Fac, Dept Biochem, Istanbul, Turkey
[2] Istanbul Univ, Cerrahpasa Med Fac, Dept Internal Med, Istanbul, Turkey
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1999年 / 48卷 / 12期
关键词
D O I
10.1016/S0026-0495(99)90233-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We examined the in vitro susceptibility of red blood cell (RBC) lipids to oxidation in type 2 diabetic patients with or without angiopathy. Lipid peroxidation was assessed by quantifying thiobarbituric acid (TBA) reactivity as malondialdehyde (MDA). We also examined the RBC antioxidant status by determining glutathione (GSH) levels. Before in vitro oxidation, RBC MDA levels were significantly higher in both diabetic groups than in the controls (P <.001), and a significant difference was found between the two diabetic groups (P <.05). Alter in vitro treatment of RBCs with hydrogen peroxide, the degree of lipid peroxidative damage was significantly higher in diabetic patients with angiopathy versus diabetics without angiopathy (P <.001). Diabetic patients have low RBC GSH levels compared with controls, and after in vitro oxidation, the levels were significantly decreased in diabetics (P <.001). There was not a significant correlation between RBC MDA levels and glycated hemoglobin (GHb), plasma cholesterol, and triglyceride. The correlation between RBC MDA and GSH was weak (P <.001). We suggest that the results of this study might help to clarify the role of oxidative mechanisms as an in vitro model of degenerative damage in type 2 diabetic angiopathic complications. Copyright (C) 1999 by W.B. Saunders Company.
引用
收藏
页码:1481 / 1484
页数:4
相关论文
共 30 条
[1]  
ALTOMARE E, 1992, DIABETES METAB, V18, P264
[2]   IMPAIRED ACTIVATION OF GLUCOSE-OXIDATION AND NADPH SUPPLY IN HUMAN ENDOTHELIAL-CELLS EXPOSED TO H2O2 IN HIGH-GLUCOSE MEDIUM [J].
ASAHINA, T ;
KASHIWAGI, A ;
NISHIO, Y ;
IKEBUCHI, M ;
HARADA, N ;
TANAKA, Y ;
TAKAGI, Y ;
SAEKI, Y ;
KIKKAWA, R ;
SHIGETA, Y .
DIABETES, 1995, 44 (05) :520-526
[3]   ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES [J].
BAYNES, JW .
DIABETES, 1991, 40 (04) :405-412
[4]  
BEUTLER E, 1963, J LAB CLIN MED, V61, P882
[5]  
COSTAGLIOLA C, 1990, CLIN PHYSIOL BIOCH, V8, P204
[6]   ENHANCED SERUM LEVELS OF THIOBARBITURIC ACID-REACTIVE SUBSTANCES IN DIABETES-MELLITUS [J].
GRIESMACHER, A ;
KINDHAUSER, M ;
ANDERT, SE ;
SCHREINER, W ;
TOMA, C ;
KNOEBL, P ;
PIETSCHMANN, P ;
PRAGER, R ;
SCHNACK, C ;
SCHERNTHANER, G ;
MUELLER, MM .
AMERICAN JOURNAL OF MEDICINE, 1995, 98 (05) :469-475
[7]  
GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819
[8]   EFFECT OF GLYCEMIC CONTROL, RACE (WHITE VERSUS BLACK), AND DURATION OF DIABETES ON REDUCED GLUTATHIONE CONTENT IN ERYTHROCYTES OF DIABETIC-PATIENTS [J].
JAIN, SK ;
MCVIE, R .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1994, 43 (03) :306-309
[9]   NEW APPROACHES TO THE PATHOGENESIS AND TREATMENT OF DIABETIC MICROANGIOPATHY [J].
JENNINGS, PE ;
BARNETT, AH .
DIABETIC MEDICINE, 1988, 5 (02) :111-117
[10]  
JONES AF, 1988, DIABETES RES CLIN EX, V7, P89